Home drug
 

Keywords :   


Tag: drug

Merck Submits New Drug Application to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes

2014-11-24 14:00:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes, to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Language: English Contact: MerckMedia:Pam Eisele267-305-3558orKim Hamilton908-740-1863 / 908-391-0131orInvestors:Justin Holko908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: for type application medical

 

Nashua men charged in January drug deal shooting plead guilty

2014-11-21 06:48:19| Paper - Topix.net

Two Nashua men charged in a shooting during a botched drug deal pleaded guilty this week and were sentenced to several years in state prison. Alexandre Amado, 21, formerly of 15 Kessler Farm Drive, pleaded guilty to second-degree assault and armed robbery and will spend five to 10 years in prison after admitting to accidentally shooting Danny Vorn in the head on Jan. 9 on Rochette Avenue while trying to rob him of 5 pounds of marijuana.

Tags: january men deal drug

 
 

Nashua men charged in January drug deal shooting plead guilty

2014-11-21 06:13:01| Industrial Machines - Topix.net

Two Nashua men charged in a shooting during a botched drug deal pleaded guilty this week and were sentenced to several years in state prison. Alexandre Amado, 21, formerly of 15 Kessler Farm Drive, pleaded guilty to second-degree assault and armed robbery and will spend five to 10 years in prison after admitting to accidentally shooting Danny Vorn in the head on Jan. 9 on Rochette Avenue while trying to rob him of 5 pounds of marijuana.

Tags: january men deal drug

 

Gilead Buys Shortcut For FDA Drug Review For $125 Million

2014-11-20 19:13:00| Biotech - Topix.net

How much is a fast track for the Food and Drug Administration review of a new drug worth? Try $125 million. In an auction, Gilead Sciences, a maker of HIV and hepatitis medicines, just bought a coupon good for the accelerated review of a drug of the company's choice from Knight Therapeutics, a Canadian company.

Tags: review million drug buys

 

Foundation sells $3.3B in Vertex drug royalties

2014-11-19 22:25:57| Biotech - Topix.net

The foundation plans to use the proceeds to expand research into therapies for cystic fibrosis, a deadly inherited illness that causes sticky mucus buildup in the lungs and other organs. The foundation first approached executives at Vertex's predecessor company in 1998 about drug development possibilities.

Tags: foundation drug sells vertex

 

Sites : [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] next »